Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum Disorder for Subjects That Have Completed Participation in 331-201-00148
Clinical trial NCT04258839 · COMPLETED
Trial details
- NCT number
- NCT04258839
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-23
- Primary completion
- 2023-03-16
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.